drugset / Trial / NCT00335647

Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma

NCT00335647

Phase 1/2 Completed 30 enrolled Immune Control
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as fluphenazine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I/II trial is studying the side effects and best dose of fluphenazine and to see how well it works in treating patients with refractory advanced multiple myeloma.

Timeline

Start
2006-01
Primary completion
2008-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluphenazine Small molecule Intravenous

Indications